anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Source Note

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 110,355
Current window 73,111-73,140
Pages 3,679
Rows per page 30
Component: Source Noteclear collectionreset all
18 30 60

Component

73,111-73,140 of 110,355

filter-aware
23
Uses a nested circle diagram to illustrate market segmentation and penetration.Sonos | Results Presentation Deck | 33 slides · Sonos
Conference presentation Investor relations 1 hit
26
Uses a nested circle diagram to show market segmentation and penetration.Sonos | Results Presentation Deck | 33 slides · Sonos
Conference presentation Investor relations 1 hit
28
The slide tracks the shift in revenue mix towards higher-margin channels.Sonos | Results Presentation Deck | 33 slides · Sonos
Conference presentation Investor relations 1 hit
08
The slide shows two line charts tracking market share growth in different care settings.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Need1 hit
09
The slide highlights consistent growth in both metrics, with Q/Q growth percentages annotated above each bar.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Need1 hit
10
Uses a Venn diagram to illustrate the patient segments (Dexterity Challenges, Cognitive Impairment, Suboptimal PIFR) that define the addressable population.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
13
The slide illustrates how findings from one study (PIFR-1) informed the design of a subsequent study (PIFR-2) by narrowing the patient population to GOLD 3/4, resulting in statistically significant improvement.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
16
The slide uses a combination of a market sizing summary at the top and a competitive landscape table at the bottom.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
17
The slide uses a classic 'problem vs. solution' or 'market gap vs. strategic imperative' structure.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
20
The slide provides a standard financial reconciliation table.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Action1 hit
22
The chart shows a significant reduction in operating expenses from 2020 to 2023.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Action1 hit
24
The table displays projected royalties, net sales, and milestone payments from 2023 to 2026.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Action1 hit
25
Uses a curved arrow diagram to represent a progression or portfolio of value drivers.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Action1 hit
27
Standard pharmaceutical product disclosure slide.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
28
Includes a footnote referencing market research methodology.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
31
The slide uses a mathematical equation format to explain the revenue recognition process.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
06
The slide uses a four-column layout to delineate business units, each with a strategic objective and supporting bullet points.UBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
08
The slide uses grouped bar charts to compare UBS and Credit Suisse performance metrics.UBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
10
The chart shows a projected decline in RWA from 55bn in 2Q23 to 28bn in YE26.UBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
12
The chart shows a bridge from current state to 2026 exit rate via four strategic levers.UBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
14
The chart illustrates the impact of the Credit Suisse acquisition on 2Q23 results.UBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
15
The slide uses two waterfall charts to explain the financial impact of the Credit Suisse acquisition.UBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
16
The slide uses stacked bar charts to illustrate capital structure in absolute terms (bn) and relative terms (%), comparing current status to regulatory requirements.UBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
17
The chart shows the reduction of drawn SNB facilities from 120bn to 0 between March and August 2023.UBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
18
The chart uses a waterfall-like structure to bridge divisional performance to total group performance, highlighting the impact of integration-related expenses.UBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
19
The chart uses a standard waterfall bridge to show the transition from reported to adjusted figures.UBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
20
The slide uses a combination of a data table for revenues/expenses and a waterfall chart for pre-tax income, with a callout box explaining the Corporate Center losses.UBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
21
The slide uses a waterfall bridge to explain the transition from current performance to future targets.UBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
25
The slide uses a waterfall bridge framework to explain the variance between two reporting periods.UBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · Action1 hit
29
The slide highlights a strong liquidity position with a 175% LCR in 2Q23 and a diversified pool of 257bn in high-quality liquid assets.UBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · Action1 hit